Literature DB >> 18955207

Incidental cases of subacute cutaneous lupus erythematosus in association with malignancy.

Regina Renner1, Michael Sticherling.   

Abstract

Malignancy and chronic inflammatory diseases seem to be associated to one another. Here we review the literature regarding subacute cutaneous lupus erythematosus (SCLE) and concomitant neoplasia on the basis of 3 short case reports of patients with SCLE who developed breast cancer and lung cancer respectively after long-term disease activity and immunosuppressive therapy. Possible hypotheses for this co-incidence could be: i) malignancy as a consequence of chronic inflammation, ii) malignancy as a consequence of immunosuppressive therapy, iii) paraneoplastic disease, iv) local malignancy following a persisting proliferative or reparative process or v) only coincidental occurrence.

Entities:  

Mesh:

Year:  2008        PMID: 18955207     DOI: 10.1684/ejd.2008.0522

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  5 in total

1.  Subacute cutaneous lupus erythematosus - paraneoplastic to gastric adenocarcinoma?

Authors:  Maruška Marovt; Pij B Marko
Journal:  Wien Klin Wochenschr       Date:  2017-04-18       Impact factor: 1.704

2.  [Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus].

Authors:  M Sticherling
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

3.  Update on Epidemiology and Clinical Assessment Tools of Cutaneous Lupus Erythematosus and Dermatomyositis.

Authors:  Yunyoung C Chang; Victoria P Werth
Journal:  Curr Dermatol Rep       Date:  2013-01-24

Review 4.  Cutaneous lupus erythematosus: An update.

Authors:  Carina M Grönhagen; Filippa Nyberg
Journal:  Indian Dermatol Online J       Date:  2014-01

5.  Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report.

Authors:  Noelle Y Wong; Laurie M Parsons; Martin J Trotter; Roger Y Tsang
Journal:  BMC Res Notes       Date:  2014-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.